Defra has announced that Great Britain is to be declared bluetongue-free from 5th July 2011.
From this date, bluetongue susceptible species being exported from Great Britain will no longer need to be vaccinated against BTV8 or meet any of the other 'Annex III conditions.
However, the current EU Bluetongue Directive only allows bluetongue vaccination within a protection zone, so from 5th July vaccination will no longer be permitted in Great Britain.
The British Veterinary Association is supporting Defra to lobby for these rules to be changed to allow vaccination in bluetongue areas.
Harvey Locke, BVA President, said: "The move to bluetongue freedom is thanks to the excellent partnership between government, farmers and vets across Great Britain. It is a tremendous achievement to turn the situation around from the outbreak in 2007 to freedom in 2011.
"We are disappointed that changes to the EU Directive to allow vaccination to continue could not be made before the deadline and we will continue to work with Defra to try to secure this change as soon as possible to allow vets and farmers to make the right choice to protect their herds.
"Those farmers and vets that wish to vaccinate must do so before the 5th July.
"The BVA would reiterate the message to farmers to source stock responsibly to help avoid a future outbreak."
Novartis has made a last call for entries to its competition in which you can win an iPad whilst getting the latest update on the correct use of NSAIDs from an acknowledged expert in the field.
To enter the competition, watch the first in a series of webcasts by Dr Jo Murrell, Senior Lecturer at Bristol Vet School, then answer three questions about what you've seen.
Competition closes at the end of May. More information here.
The RCVS Council has approved the new Strategic Plan designed to bring the College closer to its vision of enhancing society through improved animal health and welfare, over the next three years.
The Strategic Plan is founded on feedback from the profession and the public about what the College does well and where it could do better, and an analysis of how other leading regulators operate. It includes 35 actions, clustered under five themes, all centred on the purpose of setting, upholding and advancing veterinary standards.
For example, the College aims to introduce a service charter - for the public and the profession - of rights, expectations and responsibilities for each of its functions.
Nick Stace, RCVS CEO said: "This drive for excellent service lies at the heart of our focus on improvement.
"The concept of veterinary surgeons and veterinary nurses, as well as the public, being our 'customers', was one that unsettled the profession when it was first mooted. But I believe that only by ensuring that we focus relentlessly on improving how we interact with our customers will we deliver a service for the profession, the public, and, ultimately, the UK's animals, which is worthy of the name first-rate regulator."
Amongst other things, the Plan also commits to:
The Strategic Plan can be downloaded from www.rcvs.org.uk/strategy.
Also at its November meeting, Council approved:
More information on all of these topics will be available in the November issue of RCVS News, online shortly at www.rcvs.org.uk/publications.
You can also hear direct from the CEO via his post-Council video update: www.youtube.com/rcvsvideos.
Researchers from Highcroft Veterinary Referrals, the Royal Veterinary College and the University of Zurich are asking veterinary surgeons to take part in a survey designed to identify the rate of complications associated with Angiostrongylus vasorum (lungworm) infection or treatment in dogs.
The research, which is led by Drs Kieran Borgeat, Jose Matos and David Connolly, is the first step of a larger project, which hopes to culminate in the development of a set of consensus guidelines for the diagnosis and treatment of lungworm in dogs.
The researchers say that the guidelines are needed because there is currently no consensus amongst veterinary practitioners as to how dogs infected with Angiostrongylus vasorum (lungworm) are best treated. In addition, whilst there are anecdotal reports of adverse reactions after treatment, none are currently published in the literature.
The survey takes less than 10 minutes to complete, and all participants who leave their email address will be entered into a prize draw for £100 worth of Amazon vouchers.
No pharmaceutical or food companies have been involved in the design or funding of the research, and approval has been granted by the RVC Ethics and Welfare Committee.
The survey will close on 1st May 2016, or when 1000 responses have been completed. All information entered into the questionnaire will be completely anonymous and contact information will be held in a confidential database and not shared with any third parties.
To take part, visit http://tinyurl.com/lungwormsurvey
Researchers at the Animal Health Trust are appealing for information from veterinary surgeons who have seen recent Eosinophilic Keratitis (EK) conditions, an emerging issue in UK equine ophthalmology.
The AHT says that despite the increased awareness of EK worldwide, the aetiopathogenesis of the disease remains poorly understood and probably underdiagnosed. The charity is looking to define the pathogenesis and determine why some horses are particularly susceptible to this condition, in particular looking for epidemiological links, environmental factors and parasitic infestation.
Many of the clinical signs of EK are non-specific and similar to other corneal conditions such as blepharospasm, chemosis, conjunctival hyperaemia, epiphora or perilesional oedema. More specific signs include caseous mucoid discharge and white/yellow plaques often localised in the peripheral cornea. The degree of pain varies and concurrent ulceration is almost always present. Conjunctivitis may also occur in association with the keratitis or as a unique disease entity.
EK can have variable clinical presentations, from a thick caseous accumulation to a more superficial plaque of “ground-glass” appearance. They may present as chronic non-healing ulcers that respond quickly to the use of topical steroids and/or ciclosporin, or present with marked ocular discomfort and require superficial keratectomy to resolve the condition.
Two different corneal locations are classically (though not exclusively) involved in EK, the medial perilimbal cornea, often under the third eyelid, or the lateral perilimbal cornea, which may progress axially towards the central cornea.
The charity is also providing free cytology tests for corneal scrapes to help vets diagnose EK earlier, thereby avoiding secondary complications that can lead to permanent visionary impairment.
If you have seen cases that have either been diagnosed as or that you suspect to be Eosinophilic Keratitis this year, contact Sonia Gonzalez-Medina on 01638 751000 Ext: 1203 or sonia.gonzalez-medina@aht.org.uk.
For more information and to download a copy of the submission form to accompany samples, visit www.aht.org.uk/EKstudy.
The review coincided with a move last month from RUMA, the agricultural and food industry alliance which promotes responsible use of medicines in farm animals, to align with the EMA position.
The announcement means that under PVS guidelines, fluoroquinolones, 3rd and 4th generation cephalosporins and colistin will retain Class 3 status. This means they are only used when no other options are available and when supported by laboratory sensitivity testing – or exceptionally when all other options have failed.
Class 1 antibiotics form the standard prescribing list within responsible use guidelines and Class 2 are used only when sensitivity tests or clinical experience proves standard antibiotics are not effective. In all treatment decisions the health and welfare of the pigs must always take priority.
Betalactams with betalactamase inhibitors (clavulanic acid) were previously in the highest priority Class 3 but in light of the list defined by the EMA, which has been adopted by the Veterinary Medicines Directorate as well as RUMA, the PVS has reassessed the risk and moved them to Class 2 to align them with plain betalactams. This means they are still subject to voluntary restrictions, but their use would not necessarily be only as a last resort.
PVS president Mark White said that despite the ongoing review process and the potential to reclassify certain products, the Society’s underlying principles remain unchanged: "The total amount of all antibiotics used on pig farms to treat and prevent disease should be minimised, and the types of antibiotics used in pigs should be considered in light of the implications for antibiotic resistance challenges in both pigs and man.
"This policy is proving successful with AHDB Pork’s electronic pig medicine book (e-MB) recently showing that use of colistin appears to have fallen by over 70% in 2016 following its move to a Class 3 antibiotic in late 2015.
"We must also continue to be alert to the possibility of cross resistance, even in older antibiotics that have little or no use in humans. Risk must be acknowledged where it exists and overall reductions are still imperative."
RUMA has welcomed the review and alignment from the PVS. Secretary General John FitzGerald said: "Farmers and vets need boundaries within which to operate and clear objectives to meet, and we would urge all supply chains, from farmer to retailer, to align with the sector position on best practice use of antibiotics, as defined by each sector’s professional veterinary organisation."
The range will include Vetoryl 20mg, 30mg and 60mg hydrolysed chicken flavoured tablets, which can be broken into halves or quarters.
The new Vetoryl tablets will come in packs of 30 tablets, although no word from Dechra as to when they'll arrive.
Thomas Johnson, Vetoryl brand manager at Dechra, said: “We are delighted that Vetoryl Flavoured Tablets for Dogs will soon be available, which will provide vets and pets owners with easy to administer, flavoured tablets to provide additional dosing flexibility.
"This, together with our commitment to providing extensive technical support and resources, will ensure that Vetoryl continues to be the UK’s leading licensed medical treatment for Cushing’s syndrome.”
Dechra Veterinary Products has launched a case study competition to find out how veterinary professionals are using Celox, its new haemostatic agent designed to stop heavy bleeding.
According to the company, Celox Veterinary forms a gel-like clot within 30 seconds when mixed with blood.
Dechra says it would like examples of how it has been used, whether for planned procedures or in an emergency, and is asking veterinary surgeons and nurses to send in case histories and photos for the chance to win an iPad2.
Rachel Horton, Dechra's Brand Manager for Woundcare, said: "Celox Veterinary was launched to the market last year, with the human version of the product being used with great success on the battlefield by the British military for several years.
"Now we are asking veterinary professionals to share their experiences of using Celox Veterinary in practice, whether used in its gauze or granular form. It is ideal for fast-acting haemostasis, and provides a quick and efficient solution wherever and whenever bleeding needs to be stopped fast.
"Entrants providing case histories with accompanying photos can enter as many times as they like and have a chance to win an iPad2. Learning about how veterinary professionals are using products is important to Dechra Veterinary Products and assists in developing the high level of support we offer to vets and vet nurses."
Dechra says Celox Veterinary is being used not only for trauma injuries and emergency first aid but also for planned operations including castration, mass removal, nasal polyps, dental extractions and soft palate resections.
Case histories should be emailed to Rachel.Horton@dechra.com before the closing date of July 20th 2012 to be eligible for the draw. For further information about Celox Veterinary, please visit see www.dechra.com
Amy Bergs MRCVS, owner of The Cat Doctor in Surrey and co-founder of the new British Mobile Veterinary Association, has won a week's worth of free advertising for her practice on national TV.
The competition was run by the mobile payments company iZettle, which invited entrants to submit a 15 minute video about their business.
Amy's husband and business partner Robert put the video entry together. It was one of seven winners picked out of hundreds that iZettle said it received.
The resulting advert (below) is being shown on a number of TV channels, including Sky News, Sky Sports and Comedy Central, from today.
Amy said: "We are so excited to have won the competition. We love what we do and would like to help more cats, it’s such an amazing opportunity to share what we can offer on national television!"
watch?v=Vi8SCWcPJoo
The service has been free of charge since March 15th 2020, when it first became clear how difficult things would become. However, as life has become less restricted, now seemed an appropriate time to introduce a very modest charge to help with the site's ongoing development and maintenance.
Over the last four and a half months, there has been a significant increase in the number of jobs advertised on VetSurgeon (to the extent that VetSurgeon and VetNurse Jobs now have more jobs advertised than either the Veterinary Times or the Veterinary Record). What's more, feedback from advertisers is that they've received more enquiries both on VetSurgeon.org and over on VetNurse Jobs.
On VetSurgeon, this may be due in part to a number of locum vets seeking permanent positions. However, it also seems likely to be a consequence of a 'virtuous circle' whereby more jobs advertised = more visibility on Google and other social networks = more enquiries = more jobs advertised = more visibility and so on.
For this reason, the plan for the future is to optimise the price of advertising on VetSurgeon.org at the lowest level needed to encourage the largest number of vacancies, the greatest number of enquiries and the revenue needed to pay for the ongoing running of the sites.
For more information about recruitment advertising on VetSurgeon.org.
The studies and articles include a look at the importance of ethics, artificial Intelligence in veterinary practice, retention in the veterinary nursing profession, canine corneal bacterial pathogens, canine appendicular soft tissue sarcomas and mast cell tumours, and autologous mesenchymal stromal cell treatment.
Professor Luisa De Risio, Clinical Research and Excellence Director at Linnaeus, said: “Innovation in clinical research can only happen if we embrace change in society – from new technology to improvements in animal welfare. As well as showcasing the latest research, our new report also brings together experts to consider the opportunities for our profession.”
https://bit.ly/42KFrMK
Defra's Chief Veterinary Officer's annual report was published this week, reviewing developments in animal health and welfare during 2007.
The report, by former Chief Veterinary Officer (CVO) Fred Landeg, summarises progress and developments in the field of animal health and welfare within Great Britain. It also provides a continuous statistical record of the state of animal disease in Great Britain.
Topics covered in the 2007 report include the outbreaks of Foot and Mouth Disease, Avian Flu and Bluetongue, and progress on the UK's Responsibility and Cost Sharing Programme.
Other major areas covered in the report are:
A copy of the full report can be found at http://defraweb/animalh/cvo/report.htm
The British Veterinary Association (BVA) has welcomed the Kennel Club's confirmation that, from January 2010, all dog owners and breeders wishing to participate in the Kennel Club/BVA Canine Health Schemes (CHS) for eye disease and hip and elbow dysplasia will be required to have their dogs permanently identified with either a microchip or tattoo.
BVA President Nicky Paull said: "This move has been introduced at the express wish of the veterinary profession through the BVA and we are delighted that the Kennel Club has taken our view on board.
"In November, following discussion at our Ethics & Welfare Group, we called, along with an independent review of the breeding of dogs, for the permanent identification of all registered pedigree dogs. The inclusion of this requirement for participation in the Canine Health Schemes is hopefully the first step."
Diverse Undertakings Ltd. has announced that it is extending its services to include support for veterinary practices in securing their RCVS Practice Standards Scheme (PSS) accreditation.
The company was originally formed to provide business advisory services to small and medium sized enterprises across a range of industry sectors. Its services range from general H.R. advice, health & safety guidance and facilities management to candidate sourcing and call-centre services.
However, with previous experience supporting a substantial veterinary practice in Kent for both employment challenges and PSS accreditation, Company Director Neal Palk decided to extend the company's capability to support other veterinary practices in securing their PSS accreditation.
He says that because the needs of each practice vary, Diverse can adapt its service to reflect both the individual circumstances relating to accreditation as well as the capability/capacity with the practice to undertake necessary tasks itself. By using a network of associates, he says Diverse can call upon other specialities (for example - competitively priced office/building equipment) to smooth the progress to accreditation.
Diverse says it offers a range of transparent pricing options to suit the client which, without the overheads of large consultancies, often result in PSS accreditation being achieved for less cost than a typical administrative temp for a month. Monthly retention fee alternatives for other services are available, beginning at £95+ VAT.
Neal said: "Several organisations offer professional services to the veterinary practice sector, but few can claim to have 'been there, done that' and really understand the climate and culture the sector operates within. Diverse Undertakings Ltd. values its experience in the sector and aims to work with other practices to achieve both accreditation and wider business success."
For more details please contact Neal on 07771 843719, e-mail: info@diverseundertakings.com, or visit: http://www/diverseundertakings.com
The British Association of Veterinary Emergency and Critical Care (BAVECC) is carrying out a survey of the veterinary profession about 24/7 emergency veterinary cover, the results of which will be presented to the RCVS Standards Committee during its forthcoming review.
Toby Birch MRCVS from BAVECC said: "We are aware that there has been much debate on the subject however we feel that much of what has been aired is subjective opinion. While we appreciate that this is very valuable, BAVECC would like to try and place some objectivity on this matter."
If you're working in small animal practice in the UK, please take part in the survey here: https://www.surveymonkey.com/s/JYKNC5J.
The results will be shared with members of VetSurgeon.org and VetNurse.co.uk in due course.
The map gives an overview of the regulation applying to virtual care in different countries and it shows how virtual veterinary care is regulated predominantly in Western European countries only.
For the countries where veterinary virtual care is subject to regulation, the new map shows which countries:
https://vvca.org/resources/europe
The Royal College of Veterinary Surgeons has announced that Andrea Jeffery, the first veterinary nurse to sit on RCVS Council, will take up her place from July this year.
According to the RCVS, the move recognises the increasing importance of veterinary nursing as a profession, and the need for veterinary nurse input on decisions of governance that impact on the whole veterinary team.
The composition of RCVS Council is dictated by the Veterinary Surgeons Act 1966: 24 elected veterinary surgeons, two appointees from each of the six approved veterinary schools and four members appointed by the Privy Council (usually three lay people and the Chief Veterinary Officer).
Within this mix, there has not thus far been a place for a veterinary nurse, however, the vet school appointees do not both have to be veterinary surgeons, and the University of Bristol has nominated Andrea, who will take up her place at RCVS Day on 2 July.
A past Chairman, and elected member of the RCVS Veterinary Nurses Council, Andrea is Programme Director of the Veterinary Nursing and Bioveterinary Science Programme at the University of Bristol. Liz Branscombe will continue as Chairman of the Veterinary Nurses Council, and makes a report to RCVS Council each time it sits - in March, June and November.
Andrea said: "I am very grateful to Bristol for being forward-thinking and enabling a veterinary nurse to sit on RCVS Council in this way. This opportunity gives veterinary nursing a voice on Council and recognises the growing maturity we have as a profession, and the contribution of veterinary nurses to the practice team. I look forward to supporting the work of Liz and the Veterinary Nurses Council."
RCVS President, Sandy Trees said: "The legislation that defines the composition of RCVS Council was put in place when veterinary nursing was in its infancy. However, I am delighted that the University of Bristol has been imaginative enough to choose Andrea as one if its appointees. It is the same spirit of doing as much as we can to modernise, in the absence of new legislation, which has led us to introduce the non-statutary regulation of veterinary nurses and the voluntary Practice Standards Scheme."
CVS has announced that it is to support the Small Animal Veterinary Surveillance Network (SAVSNET), a charity initiative run jointly by the BSAVA and the University of Liverpool to monitor health and illness in companion animals using anonymised data from veterinary practices and laboratories.
The group will be linking its practices, of which there are now more than 290, to SAVSNET through their practice management systems in a rollout that will continue until the end of the year.
Through its research and analysis, SAVSNET aims to monitor disease trends over time; identify populations at risk and monitor treatments and outcomes. It also aims to provide data and improve public awareness of small animal diseases and prevention. One of its projects delivers near-real-time (within 24 hours) practice-based syndromic surveillance based on data received from participating veterinary surgeons, who through a single mouse click, record information at the end of each consultation through their practice management system. The data is automatically sent to SAVSNET for secure storage and analysis. The whole process is designed to avoid any impact on a practices already busy work flow.
Dr Alan Radford, one of SAVSNET’s principal investigators, said: "Reusing electronic health data has a massive potential to improve animal and human health. SAVSNET is one project leading the way in this research and it is great to be working with CVS, with its scale and also its focus on high quality veterinary care.
"Working together, SAVSNET and members of the CVS team can really help understand in a new way the diseases seen by the populations under our care. As a small thank you for participation, practices that take part are provided with a secure on-line portal where they can see free anonymised benchmarking statistics including disease data and antibacterial use. Greater knowledge will enable us to target interventions to those animals most at risk, to identify risk factors for disease and to focus veterinary research efforts."
Marcus Evans, Head of Practice Management Systems at CVS said: "We are very impressed at the projects being carried out by the SAVSNET team and are keen to support its work, particularly as our veterinary teams can do it so quickly and easily through RoboVet, our practice management system. As a large veterinary group, and one that is continuing to grow rapidly, our support will add significant weight to SAVNET's efforts and we are delighted to be contributing to such valuable research."
The Evidence-Based Veterinary Medicine Learning Consortium has announced the launch of a new online tutorial (www.ebvmlearning.org) designed to make evidence-based veterinary medicine (EBVM) accessible to the veterinary profession worldwide.
The online tutorial, funded by the RCVS Knowledge Target Grants initiative and led by Dr Kristen Reyher at the University of Bristol along with Drs Rachel Dean and Marnie Brennan from the Centre for Evidence-based Veterinary Medicine at the University of Nottingham, begins with an introductory module and then focuses on the five key areas of EBVM:
The learning resource, which can be used on various platforms and devices, is suitable for students and practitioners for self-study, and can be used as a stand-alone tutorial or as individual teaching modules to support other EBVM teaching or continuing professional development.
The online tutorial uses best educational practice and includes formative multiple choice questions, short tasks and recommendations for further study. It is intended to be a source of knowledge, bringing together the essentials of EBVM into one place, and highlights many other links to resources and organisations that are available to further learners’ knowledge about the subject.
Dr Kristen Reyher, Senior Lecturer in Farm Animal Science in the School of Veterinary Sciences, who led the project team, said: "It is hoped that the development of this resource will increase awareness of EBVM in the veterinary profession, and allow practitioners the opportunity to develop the skills needed to utilise EBVM in everyday clinical practice."
Future aims of the project team include designing methods of cataloguing and disseminating evidence synthesis to support clinical decision-making and evidence-based veterinary practice, improving and standardising the teaching of EBVM to undergraduate and postgraduate students at veterinary schools internationally, and building a community of practice in this area.
Clients should be advised that exposure to small quantities of concentrated permethrin can cause severe and fatal poisoning in cats. If they have one of the products, it should be returned to the place it was bought, or returned to the company:
John Tharratt, Bio-Tech solutions. Telephone 08704 450154. Email: JTharratt@btsl.uk.com
Help spread the word - share this post on Facebook.
MSD says the Summer Staycation campaign is designed to support the needs of new dog owners and those taking their dogs to areas outside their local region, where parasites risks will be different.
The campaign offers veterinary practices a range of resources, including client emails, a downloadable guide to parasites, social media posts and an interactive risk checker on the Keeping Britain's Pets Healthy website. There is also some training for front of house staff and receptionists at https://www.msd-animal-health-hub.co.uk/cpd/staycation.
Nicola Barclay, Senior Product Manager at MSD Animal Health said: "Summer holidays will be taking a different form this year with most people planning trips in the UK, making it more likely they will take their pets.
"What's important is that seasoned and new owners alike are aware of the parasite risks in the places they're visiting so they aren't putting the health of their pets at risk.
"We're therefore providing a range of resources to help veterinary practices encourage pet owners to make sure there are no breaks in their parasite protection and vaccinations and that they are appropriately protected for the places they'll be visiting."
Dr Ian Wright, Head of ESCCAP UK & Ireland added: "The research findings from The Big Tick Project in 2015 found that 1 in 3 dogs coming into veterinary practices during the summer months had ticks on them.
"Research is also showing many parasites extending their range with an increased risk of human and pet exposure. Warming temperatures mean that ticks can be encountered all year round in the UK, carrying potentially dangerous pathogens to dogs and people including Lyme disease and Tick-borne encephalitis virus (TBEV).
"With so many new dog owners and people being more likely to holiday in the UK, making sure dog owners understand the risks, while keeping them in proportion, and giving appropriate protection advice is vital.''
For more information, contact your MSD Animal Health account manager.
The BSAVA says it has produced the leaflet because of fears that so many of the puppies bought during lockdown will have missed out on this important part of their development, potentially leading to behavioural issues as they get older.
The Q&A explains the most important aspects of socialisation, both at home and outdoors. It can be downloaded here: https://www.bsavalibrary.com/files/editorial/Puppy-Socialisation-QandA.pdf
The ‘top 10 tips’ are presented as an infographic designed to be shared on social media. It highlights the main points pet owners should consider when socialising their puppy. You can download the Q&A here: https://www.bsavalibrary.com/files/editorial/Puppy-Socialisation-Top-Ten.jpg
Sheldon Middleton, BSAVA President said: “We have seen a surge in puppy ownership during the pandemic when opportunities to meet up were limited, which may have resulted in some puppies missing out on the key socialisation period. This accessible guide gives invaluable support to our members when discussing socialisation with clients.”
The BSAVA has also created a special collection on puppy socialisation, bringing together chapters, podcasts and leaflets covering the reasons behind the socialisation of puppies and how to do it successfully. The collection is free to access through the BSAVA Library during September: https://www.bsavalibrary.com/content/socialization.
Intervet/Schering-Plough Animal Health has announced that it has received marketing authorization from the European Commission for a single-shot vaccination schedule of its Porcilis PCV vaccine against porcine circovirus type 2 (PCV2) infections.
The new approval allows vaccination with 1 dose of 2 ml in pigs from an age of 3 weeks onwards (known as the 1 - 2 - 3 approach) in the case of low to medium levels of maternal antibodies against PCV2, and also to include reduction of mortality as an additional indication. This new single-shot application for Porcilis PCV offers additional flexibility over the currently available dosage scheme of this vaccine, which has been available in Europe since April 2009.
Intervet/Schering Plough says the major characteristics of Porcilis PCV are that: (1) it contains the Cap-2 subunit antigen coded by ORF2 and therefore induces strong immunity against PCV2 infection; (2) it is combined with XSolve, an adjuvant offering immunity until the end of the finishing period; and (3) is able to break through of all levels of maternally-derived antibodies in piglets depending on the vaccination schedule used.
The company adds that one single dose of Porcilis PCV has been demonstrated to induce both humoral and cell-mediated responses against PCV2, despite the presence of low to medium levels of maternal antibodies. According to a recent study published in Vaccine, the immunity induced by a single dose of the vaccine resulted in reductions of viremia, viral shedding and viral load in tissues in vaccinated pigs as compared to controls. Field trials have also demonstrated that vaccination of pigs at 3 weeks of age or older reduces the presence of virus load in the blood and reduces weight loss associated with PCV2 infection during the fattening period.
Infection with PCV2 is known to cause a variety of syndromes in pigs, together known as Porcine Circo Virus Disease (PCVD). Symptoms may include clinical signs such as weight loss or failure to grow, enlarged lymph nodes, difficulty in breathing, pale skin and jaundice.
CEVA Animal Health is launching a new TV advertising and marketing campaign to promote its veterinary behaviour products, DAP and Feliway, in the run up to this year's firework season.
The campaign will feature a new animated character 'Dap the Dog', who will join 'That Purple Cat' in educating pet owners on the behaviours expressed by pets that are fearful of loud noises during fireworks, and the benefits of using DAP and Feliway. The adverts will be aired throughout October on ITV2, E4, More4 and Channel 4 (London only) starting on Monday 4th October and will be seen by 11.5 million ABC1 women.
A range of firework marketing materials have been produced to support veterinary practices and help educate owners who have noise phobic pets. These include client leaflets, an A4 leaflet holder, waiting room display materials and a firework poster all featuring the characters from the advert. CEVA's petfireworkfear website - www.petfireworkfear.co.uk/ - has also been updated to include the new TV advert, downloadable versions of all materials and tips on how to prepare pets for fireworks. In addition, www.dapfordogs.com/ and www.feliway.com/ will feature a voucher offering pet owners a free 60ml spray when they purchase a DAP or Feliway diffuser from their local veterinary practice.
The support comes in light of recent research1, carried out by CEVA, that revealed 80% of pet owners have had a pet that has been afraid of fireworks, with more than half of dog owners wanting to ban them altogether because they are too upsetting for their animals.
Julia Wood, product manager at CEVA Animal Health, said: "Fireworks are the most stressful event that a pet can experience and, in most cases, owners have noticed their animals becoming visibly unsettled with 49% of dogs shaking1 and 65% of cats hiding1. The new TV advertising campaign and marketing support will educate pet owners on behaviours expressed by pets with a fear of loud noises and the importance of taking proactive action by using DAP and Feliway."
CEVA will be running its annual firework display competition amongst veterinary practices throughout October for the best decorated waiting room.
For further information on CEVA's firework campaign or its marketing support, please contact your local CEVA territory manager or call CEVA Animal Health on 01494 781510.
RCVS President Peter Jinman has announced that a review will be carried out into the circumstances that led to higher-than-expected expenditure on the College's new database and development works in the Lower Ground Floor at Belgravia House.
He said: "That the work was required was not in question, but that expenditure over the extended timescale of both projects rose above initial budgets is both to be regretted and subject to analysis as to cause."
The RCVS Officer team has asked Professor Bill McKelvey - a new member of the College's Governance Review Group - and two of the College's Privy Council-appointed Council members to look at all aspects that relate to its budgeting and expenditure process.
The setting up of the enquiry has been cleared and approved by Sir David Barnes, who chairs the RCVS Governance Review Group.
All reports from Professor McKelvey will be scrutinised by the Governance Review Group, Officers, the Planning and Resources Committee and Council.